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Isolated hepatocytes from young (4–6 mo) and old (24–26 mo) F344 rats were exposed to increasing
concentrations of menadione, a vitamin K derivative and redox cycling agent, to determine whether the
age-related decline in Nrf2-mediated detoxiﬁcation defenses resulted in heightened susceptibility to
xenobiotic insult. An LC50 for each age group was established, which showed that aging resulted in a
nearly 2-fold increase in susceptibility to menadione (LC50 for young: 405 μM; LC50 for old: 275 μM).
Examination of the known Nrf2-regulated pathways associated with menadione detoxiﬁcation revealed,
surprisingly, that NAD(P)H: quinone oxido-reductase 1 (NQO1) protein levels and activity were induced
9-fold and 4-fold with age, respectively (p¼0.0019 and p¼0.018; N¼3), but glutathione peroxidase 4
(GPX4) declined by 70% (p¼0.0043; N¼3). These results indicate toxicity may stem from vulnerability to
lipid peroxidation instead of inadequate reduction of menadione semi-quinone. Lipid peroxidation was
2-fold higher, and GSH declined by a 3-fold greater margin in old versus young rat cells given 300 mM
menadione (po0.05 and pr0.01 respectively; N¼3). We therefore provided 400 mM N-acetyl-cysteine
(NAC) to hepatocytes from old rats before menadione exposure to alleviate limits in cysteine substrate
availability for GSH synthesis during challenge. NAC pretreatment resulted in a 42-fold reduction in cell
death, suggesting that the age-related increase in menadione susceptibility likely stems from attenuated
GSH-dependent defenses. This data identiﬁes cellular targets for intervention in order to limit age-re-
lated toxicological insults to menadione and potentially other redox cycling compounds.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A major hallmark of aging, and a key driver for the onset of age-
related pathophysiologies across multiple species, including pri-
mates, is the disruption of cellular redox homeostatic mechanisms
that protect against a variety of environmental, oxidative, patho-
logical, and toxicological insults [1–6]. Nrf2-dependent phase II
detoxiﬁcation mechanisms in particular, tend to decline with age
[7–12]. The age-related decrease in these detoxiﬁcation pathways
and ensuing increase of reactive oxygen/nitrogen species (ROS/B.V. This is an open access article u
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Hagen).RNS) is well established and is causally linked to various pathol-
ogies such as cardiovascular and neurodegenerative diseases,
cancer and diabetes [13–22]. The mechanisms associated with this
loss are poorly understood; however, we have found that hepatic
Nrf2 protein synthesis declines with aging and that phase II de-
toxiﬁcation gene expression is limited [7,23,24]. However, despite
the age-related decline in basal expression of Nrf2 regulated de-
toxiﬁcation enzymes, it remains unknown whether this loss
magniﬁes the toxicological exposure effect of ROS/RNS and xeno-
biotics detoxiﬁed through these pathways. Of particular interest to
this work are the age-associated changes to resilience against
acute exposure to a redox cycling challenge.
Redox cycling compounds are prooxidant catalysts, which fa-
cilitate the transfer of electrons onto oxygen to produce reactive
oxygen species (ROS) [25,26]. These compounds are highly abun-
dant as substituents in xenobiotic compounds (e.g. redox active
metals and pesticides) [27–31], redox active pharmacophores (e.g.
anesthetics) [32], and especially, their use in pharmaco che-
motherapeutic drugs (e.g. menadione, anthracycline, adriamycin,
and doxorubicin) [33–37]. A decreased capacity to detoxify redoxnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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to xenobiotic exposures, as well as limiting some medical treat-
ment options such as antibiotics and anti-cancer chemother-
apeutics [38–41]. This is of particular importance as cancer in-
cidence increases exponentially with age [42]. Thus, it is important
to determine whether there is an age-related decline in detox-
iﬁcation of redox cycling compounds and if so, which of these
types of drugs, toxins, or environmental xenobiotics have a
heightened toxicity proﬁle.
In order to test our hypothesis that there is an age-related
decline in resilience to redox cycling compounds in the liver, we
employed an acute menadione challenge. Menadione, a derivative
of vitamin K and a redox cycling agent, and its mechanism of ac-
tion is well characterized. Herein, we show that hepatocytes from
aged rats are acutely more susceptible to menadione insult.
Moreover, while certain detoxiﬁcation enzymes involved in me-
nadione metabolism actually increase with age, the observed age-
associated vulnerability to menadione appears to stem from a
marked attenuation of Nrf2-regulated GSH-dependent detoxiﬁca-
tion pathways.2. Materials and methods
2.1. Reagents
NAC (Cat# 616-91-1), menadione (Cat# 58-27-5), NADPH (Cat#
2646-71-1), dichlorophenolindophenol (DCPIP; Cat# 620-45-1),
and protease inhibitor cocktail (Cat# P8340) were ordered from
Sigma-Aldrich (St. Louis, MO). Collagenase type IV was purchased
from Worthington Biochemical Corporation (Lakewood, NJ). PVDF
transfer membrane was purchased from Millipore (Billerica, MA).
Dicumarol (Cat# 66-76-2) was ordered from Calbiochem (Darm-
stadt, Germany).
2.2. Animals
Both young and old male F344 rats were from the National
Institute on Aging animal colonies. The rats were housed in the
Linus Pauling Institute animal facility and allowed to acclimatize
for at least 1 week prior to any experimentation. Animals were
maintained on a 12 h light cycle (7 a.m.–7 p.m.) and fed standard
chow ad libitum. All animal work was approved and in accordance
to IACUC guidelines (Assurance Number: A3229-01). The AAALAC-
accredited Laboratory Animal Resources Center (LARC) provided
management and veterinary care.
2.3. Hepatocyte isolation
Hepatocyte isolation was performed as described previously
[43]. Brieﬂy, after animal sacriﬁce via AALAC-approved protocols,
the liver was perfused via a cannula in the portal vein with Hank's
balanced salt solution, pH 7.4. Following removal of blood, liver
cells were disassociated using collagenase solution (1 mg/mL). The
resultant cell suspension was ﬁltered through sterile gauze to re-
move connective tissue and debris. Parenchymal cells were iso-
lated using gravity ﬁltration and washed three times with Krebs–
Henseleit solution, pH 7.4. Cells were resuspended in Kreb-Hen-
seleit solution and placed in a round bottom ﬂask and rotated at
room temperature for 1 h before cell count and viability were
assessed using trypan blue exclusion.
2.4. Cell and tissue lysates
For whole cell lysates, suspended cells were harvested by
centrifugation at 100 g, washed in Krebs-Henseleit solution, pH7.4, and sonicated in lysis buffer (50 mM Tris, pH 7.5, containing 1%
NP-40 (v/v), 100 mM NaCl, 2 mM EDTA, 2 mM sodium ortho-va-
nadate) with added protease inhibitors. For tissue, lysates were
obtained as previously described by Siegel et al.. [44]. Brieﬂy, tis-
sue was homogenized using a dounce homogenizer in RIPA buffer
with a volume to weight ratio of 5:1. The homogenate was soni-
cated 3 times and centrifuged for 15 min at 10,000 g cen-
trifugation (4 °C) before supernatants were collected for assays.
For the NQO1 assay, supernatants from tissue lysates were sub-
jected to an additional ultracentrifugation step (30,000 g for 1 h
at 4 °C). Protein concentrations of samples were determined either
by the Bradford Assay (Cat# 500-0006, BioRad) or Pierce 660 nm
assay (Cat# 22660, Thermo Scientiﬁc).
2.5. Assessment of menadione toxicity
Hepatocytes were diluted to 4106 cells/mL using Kreb-Hen-
seleit solution, pH 7.4, and rotated on a MACSMIX (Miltenyi Biotec)
rotator placed in a cell culture incubator (5% CO2 at 37° C) to
maintain the cells in suspension. Hepatocytes were treated with
increasing concentrations of menadione (0, 100, 200, 300, 400,
500, and 600 μM) for 2 h before being assayed for viability using
trypan blue exclusion. Menadione was solubilized in di-
methylformamide (DMF). DMF was also used as the vehicle control
and total DMF in treated cell suspensions was 0.05% by volume for
all treatment experiments.
2.6. NQO1 activity assay
NQO1 activity of samples was assayed as described previously
by Siegel et al. [44]. Brieﬂy, tissues from young and old animals
were prepared as described above before being assayed for the
NAD(P)H-dependent reduction of DCPIP by NQO1 in the presence
and absence of dicumarol (a reversible NQO1-speciﬁc inhibitor).
DCPIP reduction was assayed using a DU800 spectrophotometer at
600 nm over 1 min, and NQO1 activity was measured as the di-
cumarol inhibitable portion of the reduction. Final concentrations
of reagents in reaction solution were 0.2 mM NAD(P)H and 40 μM
DCPIP with and without 20 μM dicumarol.
2.7. Malondialdehyde quantiﬁcation
Measurement of the lipid peroxidation product, mal-
onyldialdehyde (MDA), was performed as previously described by
Wong et al. [45] and modiﬁed by Sommerburg et al. [46]. Brieﬂy,
200 mL of suspended cells (4106 cells/mL) was mixed with
750 mL of 440 mM phosphoric acid, 250 mL of 42 mM thiobarbi-
turic acid (TBA), and 300 mL of water prior to being boiled for 1 h.
The reaction was quenched by placing samples into an ice bath.
Samples then had an equal volume (1.5 mL) of 1 M NaOH added
before being centrifuged at 16,000 g for 5 min at 10° C. Mal-
ondialdehyde was separated from other metabolites by HPLC using
a Luna C18(2)] Phenomenex #00G-4252- E0) column in isocratic
mode (25 mM potassium phosphate buffer, pH 6.5/methanol
[50:50]as eluents) and detected by ﬂuorescence (excitation,
532 nm; emission, 553 nm). Malondialdehyde was quantiﬁed re-
lative to a tetramethoxypropane (TMP) standard curve.
2.8. Immunoblotting
Lysates were prepared as described above, sonicated, and
proteins were solubilized for PAGE in Laemmli loading buffer
containing SDS. Samples were heat-denatured for 5 min at 100 °C.
Normalized amounts of protein (30 μg/lane) were run on SDS-
PAGE and transferred to PVDF membranes with a semi-dry blotter.
Membranes were blocked in PBS containing 1% Tween-20 with
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Fig. 1. Acute menadione toxicity is enhanced with age. Isolated hepatocytes from
young and old rats were treated with increasing amounts of menadione (0–
600 mM). Viability was determined by trypan blue exclusion 2 h after exposure.
N¼3, *po0.05..
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tibodies for 2 h at room temperature, washed, and incubated with
secondary antibodies for 1 h at room temperature, washed, in-
cubated with chemiluminescence reagents, exposed to ﬁlm, and
developed. Images shown were cropped for size/space considera-
tions. Antibodies made to the following proteins were used: GPX4
(Protein Tech - Cat# 14432-1-AP), NQO1 (Abcam - Cat# ab2346),
Cytochrome P450 Reductase (CPR, EC 1.6.2.4; Abcam – Cat#
13513), Lactate Dehydrogenase A (LDHA; Cell Signaling Technology
- Cat# 2012) and Actin (Sigma-Aldrich – Cat# A5044). Blots were
densitometrically analyzed with ImageJ software from NIH.
2.9. Glutathione analysis
Glutathione (GSH) content of suspended cells was determined
according to the methods of Fariss and Reed [47] as modiﬁed by
Smith et al. [7]. Brieﬂy, suspensions were homogenized in an equal
volume of 10% (w/v) perchloric acid (PCA) containing 10 mM
EDTA. After deproteinization, 200 mL of the supernatant containing
internal standard (γ-glutamyl glutamate) was mixed with 50 mL
iodoacetic acid (100 mM dissolved in 0.2 mMm-cresol purple) and
the pH was adjusted to 10 by using KOH–KHCO3 buffer (2 M
KOH:2.4 M KHCO3). Samples were placed in the dark, at room
temperature for 1 h. The resulting S-carboxymethyl derivatives
were subjected to further chemical modiﬁcation by addition of an
equal volume of 1-ﬂuoro-2,4-dinitrobenzene (1% v/v in absolute
ethanol). The solution was incubated overnight in the dark and at
room temperature. Samples (75 mL) were separated by HPLC using
a Thermo Scientiﬁc (Eugene, OR) APS-2 Hypersil column and de-
tected on a Shimadzu (Kyoto, Japan) SPD-10AVP UV–Vis spectro-
photometer with the absorbance set at 365 nm. Quantitation was
obtained by integration relative to GSH and GSSG standards.
2.10. Statistical analysis
All statistical analysis was performed using Excel (Microsoft,
Inc.) and Prism 6 and 7 (GraphPad Software, Inc.). Error bars re-
present standard error of the mean. For comparisons between two
samples, two-sided Student's t-test was used. Differences between
samples that resulted in a p-value of r0.05 were considered
statistically signiﬁcant. Statistical analyses for multiple compar-
isons were evaluated by Student's t-test with the Sidak-Bonferroni
post-hoc method.3. Results
3.1. Acute menadione challenge causes hepatocellular damage and
loss of viability
To establish the relative age-associated susceptibility to me-
nadione challenge, aliquots of freshly isolated hepatocytes from
young and old rats were incubated with increasing concentrations
of menadione, and viability was assessed after 2 h of challenge.
Results in Fig. 1 show that regardless of age, increasing con-
centrations of menadione corresponded with heightened indices
of cell damage and loss of viability. For hepatocytes from young
rats, the lowest concentration of menadione employed (100 mM)
resulted in no changes in toxicity versus vehicle control; in con-
trast, hepatocytes isolated from old rats lacked any resilience to
menadione, demonstrating viability loss at all concentrations tes-
ted. The LC50 for menadione was calculated to be 405 mM and
275 mM for young and old rat hepatocytes, respectively (Fig. 1).
These results indicate a signiﬁcantly higher susceptibility to me-
nadione with age (po0.05, N¼3), and suggest that basal cellular
defenses to this redox cycling agent are compromised.3.2. Increased vulnerability to menadione with age is not caused by
a loss in NQO1 or increase in Cytochrome P450 Reductase (CPR)
Considering the mechanisms associated with its detoxiﬁcation
(Fig. 2), heightened age-dependent vulnerability to menadione
may stem from altered activities of one or more antioxidant or
phase II detoxiﬁcation enzymes. As almost all of these enzymes are
primarily regulated by Nrf2 [48–54], we sought to deﬁne potential
lesions in menadione detoxiﬁcation, which might serve as the
basis for its enhanced toxicity with age.
CPR converts menadione from the quinone to semiquinone
state; therefore, any age-related increase in the reductase would
lead to higher levels of redox cycling. However, we found that the
CPR protein decreased by 2-fold in hepatocytes from old animals
(Fig. 3A, p¼0.0137, N¼3). These results suggest that, if anything,
there may be less menadione redox cycling with age progression.
Because CPR could not account for the elevated toxicity from
menadione, we examined the hepatic levels and activity of NQO1,
as this enzyme catalyzes the two-electron reduction of menadione
to the fully reduced hydroquinone state (Fig. 2). Full reduction
limits redox cycling and initiates menadione detoxiﬁcation and
removal from cells. Rather than the hypothesized decline in NQO1
levels with age, we observed that NQO1 protein content and en-
zyme activity in livers from old rats increased markedly compared
to that seen in young animals. As shown in Fig. 3B, NQO1 activity
was nearly 4-fold higher with age (p¼0.0185, N¼3), which is
consistent with heightened hepatic protein content of the enzyme
(9.3-fold increase, p¼0.0019, N¼3) in Fig. 3C. While this sig-
niﬁcant elevation in steady-state NQO1 activity may represent an
adaptation toward the heightened pro-oxidant cellular milieu of
the aging rat liver, these results nevertheless suggest that NQO1 is
not likely a part of the mechanism associated with vulnerability to
menadione.
3.3. Age-related decline in hepatic GSH and GPX4 contribute to
menadione-mediated cytotoxicity
Menadione and the reactive oxygen species initiated by its re-
dox cycling are primarily detoxiﬁed by GSH-dependent mechan-
isms (cf. Fig. 2), which we previously reported to decline sig-
niﬁcantly with age [7]. In order to determine whether hepatic GSH
levels become limiting under menadione insult, hepatocytes from
young and old animals were treated with menadione at approxi-
mately the LC50 for old rats (300 mM). Results show that
Fig. 2. Menadione detoxiﬁcation scheme. Menadione is a potent redox cycling agent which cycles between the quinone and semi-quinone states, producing superoxide,
which may eventually lead to oxidative and nitrosative damage. NQO1 detoxiﬁes the menadione quinone by reducing it to the hydroquinone, which is then eliminated. The
major resultant oxidative damage from redox cycling is lipid peroxidation (LOO.), which is primarily detoxiﬁed by the glutathione-dependent GPX4 enzyme.
Fig. 3. CPR protein levels decrease while NQO1 protein levels and activity increase with age. CPR protein levels (A), and NQO1 activity (B) and protein levels (C) in liver tissue
homogenates from young (Y) and old (O) animals were evaluated. N¼3 for A, B and C, *p¼0.0137, 0.0185 and 0.0019 respectively.
N.O. Thomas et al. / Redox Biology 10 (2016) 45–5248menadione rapidly eliminates GSH in both age groups, but it
caused a markedly greater loss of GSH hepatocytes from old rats.
As shown in Fig. 4, menadione resulted in 480% decline in GSH
within one minute in old rat hepatocytes. The menadione-medi-
ated loss of GSH was signiﬁcantly less severe in cells from young
animals (60% decline). GSH levels at all time points were sig-
niﬁcantly different between young and old (pr0.01, N¼3).
Moreover, GSH levels in the young rat hepatocytes never de-
creased below a threshold of 35%. Thus, reserves of hepatic GSH
are more rapidly and extensively lost with age, and this pre-
cipitous decline in GSH precedes indices of cellular damage and
loss of viability.To further determine age-associated differences in GSH-de-
pendent detoxiﬁcation of menadione, we examined hepatic con-
centrations of glutathione peroxidase 4 (GPX4). This enzyme is a
primary protectant against phospholipid hydroperoxides, and is
also known to play a signiﬁcant role in protection against redox
cycling [55,56]. Western blot analysis revealed that GPX4 protein
levels were signiﬁcantly lower in old than in young hepatocytes
(Fig. 5A; 70%, p¼0.0043, N¼3), which is consistent with reports of
age-related loss in GPX4 levels in multiple tissues, including the
liver [57,58]..
Because GPX4 chieﬂy protects against lipid peroxidation, we
measured hepatic levels of malondialdehyde (MDA), a biomarker
Fig. 4. GSH loss during menadione treatment is accelerated with age. Hepatocytes
from young and old rats were treated with 300 mM menadione over a 15 min time
course and assayed for GSH content. N¼3, *pr0.01.
Fig. 6. Pretreating cells with NAC prior to menadione exposure improves re-
sistance. Hepatocytes from old animals were pretreated with vehicle (water),
400 mM NAC, or 400 mM NAC & 400 mM BSO for 1 h prior to addition of 300 mM
menadione. Viability was determined 2 h later. N¼5, *p¼0.003 versus vehicle.
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tion with thiobarbituric acid (TBA). Because TBA derivatization
may overestimate lipid peroxidation levels, we employed a well-
characterized HPLC method to minimize ex vivo artifacts so that
relative differences in lipid peroxidation with age and menadione
could be discerned. [59] It is interesting to note that, without
menadione, no age-associated differences in MDA levels were
observed, indicating that basal lipid oxidation and its detoxiﬁca-
tion are maintained despite the age-related loss of GPX4 (Fig. 5B).
However, exposure to menadione at the approximate LC50 for old
rat hepatocytes (300 mM), resulted in a rapid appearance of MDA
in cells from both age groups (Fig. 5C). Hepatocytes from aged rats
were demonstrably more vulnerable to menadione-mediated lipid
peroxidation. Initial increases in MDA levels for cells from both
young and old animals was observed, followed by a brief stabili-
zation of MDA levels between the 2 and 5 min time points. After
this, MDA levels in cells from young animals returned to baseline.
In contrast, hepatocytes from old rats displayed a rapid increase in
MDA levels after the 2 through 5-min stabilization period. After
15 min, MDA levels were 147.4713.8 and 274.2735.1 pmol/mg
protein in liver cells from young and old animals, respectively.
Moreover, lipid peroxidation levels in hepatocytes from young
animals never increased by more than 5%, whereas the extent ofFig. 5. GPX4 protein levels are signiﬁcantly reduced with age which correlates with an i
old (O) animals were evaluated for GPX4 protein levels by western blot (A). Basal MDA co
for A, B and C, *p¼0.0043, 40.05, and o0.05 for A, B, and C respectively.lipid oxidation in hepatocytes isolated from old rats were 78%
higher and still rising 15 min after menadione challenge. The di-
vergence between young and old is striking and aligns with loss of
GPX4, as well as the appearance of cellular damage and loss of
viability.3.4. Age-related menadione toxicity is reversed by GSH precursors
Because GPX4 works at the expense of GSH, and GSH is also
lowered with age in our model, we hypothesized that providing
cells with NAC should relieve the cysteine substrate limitations for
GSH synthesis, and thus increase resistance to menadione insult. A
1 h pretreatment with NAC (400 mM) before menadione exposure
signiﬁcantly increased resistance to menadione in old rat hepa-
tocytes. In fact, our data show that NAC treatment reversed the
increased age-associated vulnerability to menadione (Fig. 6,
p¼0.003, n¼5), making this indistinguishable from 300 mM me-
nadione-treated hepatocytes from young animals (Fig. 1). Co-pre-
treating with buthionine sulfoximine (BSO; 400 mM for 1 h), a
speciﬁc GSH synthesis inhibitor, eliminated the ability of NAC to
rescue hepatocyte viability, which serves as a proof of concept that
GSH is the key component.ncreased appearance of menadione-induced MDA. Hepatocytes from young (Y) and
ntent (B) and MDA accumulation (C) were assayed after menadione treatment. N¼3
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The aging process leads to disparate changes in hepatic de-
toxiﬁcation capacity. For example, many phase I enzymes are un-
affected by age, while phase II detoxiﬁcation processes are more
variable [60–62]. Our data exempliﬁes this with NQO1 levels and
activity increasing signiﬁcantly in aging hepatocytes, but GPX4
appreciably declines. Therefore, while a general age-related loss in
basal detoxiﬁcation capacity is apparent, it is not clear if this de-
cline is at least partly compensatory, or leads to vulnerability to
certain classes of xenobiotic compounds. Our present study is
important as our data supports the concept that, at least for redox
cycling compounds, (e.g. menadione) there is a profound sus-
ceptibility with age.
The current study focused on susceptibility to acute menadione
insult using freshly isolated hepatocytes from young and old rats.
This cell model is appropriate for understanding aging differences
in detoxiﬁcation because these cells retain their aging phenotype
with respect to stress resistance. It also allows for a direct as-
sessment of potential age-induced differences in hepatic detox-
iﬁcation capacity at the time of animal sacriﬁce [43]. Using this
hepatocyte model, we previously showed that steady-state Nrf2
levels signiﬁcantly decline both in hepatocytes and in the aging rat
liver [7,23,24].
We used menadione in the current study because most of the
enzymes involved in its detoxiﬁcation are Nrf2-dependent. For
example, NQO1 maintains menadione in its fully reduced hydro-
quinone state [25,26,63] prior to its further metabolism and re-
moval from the cell (cf. Fig. 2). Additionally, because menadione is
a potent redox cycling agent, its mode of acute toxicity results
from a cascade of redox cycling, lipid peroxidation, and membrane
damage [26,64–67]. As such, we chose to examine GSH and GPX4,
the principal glutathione peroxidase that is localized to mem-
branes, as the primary players in preventing cell damage from
acute menadione exposure [68–71]. While GPX1 also plays a major
role in peroxide detoxiﬁcation, it is localized to the cytosol and
thus is not the initial detoxiﬁer of menadione-induced lipid per-
oxidation. Thus, xenobiotic disposition and the extent of acute
oxidative damage ensuing from menadione exposure are largely
dependent on the hepatocellular activity of NQO1, GSH, and GPX4
—all of which are Nrf2-regulated mechanisms.
Despite this common tie to Nrf2 associated gene transcription,
we found that aging does not uniformly affect all of the enzymatic
components involved in menadione detoxiﬁcation. For example,
we observed that hepatic levels of NQO1 and its activity sig-
niﬁcantly increase with age, while CPR activity is diminished.
Overall, these results could be interpreted as an attempt by the
hepatocyte to limit levels of the semiquinone species, thereby
lowering the rate of redox cycling. However, this protective
adaptation against menadione insult in the aging rat liver is
counterbalanced by the signiﬁcant loss of GSH levels and GSH-
dependent detoxiﬁcation enzymes (e.g. GPX4). The reason(s) why
certain Nrf2-dependent genes are affected with age while other
genes do not change or decline are not presently known. With
respect to NQO1, it has been reported that with age, NQO1 levels
and/or activity decline [72], increase [73], or remain similar to that
seen in young [74]. These results may stem from the varied
methods employed to monitor NQO1. We used the reduction of
DCPIP as ﬁrst developed by Ernster et al. [75] and recently opti-
mized by Ross et al. [44]. This method has the beneﬁt of highly
purifying the cytosolic fraction through ultracentrifugation and
does not assay the reduction of menadione-cytochrome c, which
has confounding NQO2 enzymatic activity. Additionally, the NQO1
promoter region contains an embedded TRE (TPA-response ele-
ment) within the ARE enhancer [76,77] and demonstrates higher
recruitment and binding efﬁciency for Nrf2 both for basal andinduced transcription [78,79]. These factors may account for the
increase we observed in spite of Nrf2 decline. Regardless of the
precise mechanism, it is clear that NQO1 is not involved in the age-
related enhanced vulnerability to menadione that we observed in
this study.
It is equally clear that GSH-dependent defenses are compro-
mised in hepatocytes from aging rats. We and others have pre-
viously shown that hepatic GSH declines with age [7,80–84];
however, GSH remains at millimolar levels even in very old ani-
mals. Thus, it was not known prior to the present study whether
the liver is more susceptible to menadione insult that would result
from attenuated GSH concentrations. Our results show that me-
nadione causes a rapid loss of GSH in hepatocytes from both young
and old rats, but the rate and degree of GSH loss is more extensive
in older animals. This lack of capacity to maintain cellular GSH
appears to be the most important factor leading to lost resiliency
against menadione challenge with age. This concept is buttressed
by our results using NAC and NACþBSO to modulate GSH prior to
menadione insult. In particular, NAC, which supplies L-cysteine for
GSH synthesis [85–87], essentially abrogates the increased vul-
nerability to menadione in aged rat hepatocytes. Taken together,
the inability to supply GSH for detoxiﬁcation, along with dimin-
ished GPX4, potentially sets the stage for the aging cell to be
susceptible to a variety of toxins, oxidants, and environmental
mutagens.
An additional aspect revealed in this study is that GSH levels in
young rat hepatocytes never decreased below 35% of initial le-
vels versus the 90% lost by old. This suggests that when the me-
nadione-mediated oxidation crosses a critical threshold of GSH,
cellular toxicity rapidly ensues. Because mitochondria contain a
separate GSH pool that approximates this threshold level, it is
enticing to suggest that maintenance of mitochondrial GSH is
particularly important to resist menadione insult. In this regard,
loss of mitochondrial GSH has been demonstrated to cause a de-
cline in mitochondrial membrane potential [66,88–91], inducing
calcium overload and initiating necro-apoptotic pathways leading
to cell death [92–96]. We are currently investigating the role of
mitochondrial GSH in sensitizing the cell toward oxidative insult
in aging.
Finally, the results presented in this study identify a speciﬁc
cellular target to potentially improve detoxiﬁcation and xenobiotic
metabolism. There is a signiﬁcant clinical history of using NAC to
limit toxicity from acute exposure to drugs and toxins [97–99]. Our
data suggest that a similar preventative strategy of NAC adminis-
tration may be warranted to increase resistance to xenobiotic and
drug toxicity in older adults. GSH is a principal detoxicant for
environmental xenobiotics, pharmaceuticals, air pollutants, and
heavy metals. Providing NAC to increase substrate supply of cy-
steine may circumvent the age-related decline in GSH synthetic
enzymes that attenuation of Nrf2 engenders. Thus, using NAC as a
prophylactic instead of an intervention may allow GSH levels to be
maintained for detoxiﬁcation in older adults.Acknowledgments
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